GSK Investigational Site

Seremban, Negeri Sembilan 70300

0 studies enrolling now · 4 studies all time

What they study most

Arthritis, Rheumatoid, Asthma, Systemic Lupus Erythematosus

Studies at this site

• Belimumab Assessment of Safety in SLE — Completed
• Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) — Stopped early
• 6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old — Completed
• A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE) — Completed